A citation-based method for searching scientific literature

Asma Abu-Abed Abdin, Muhammad Hamza, Muhammad S Khan, Awab Ahmed. Case Rep Crit Care 2016
Times Cited: 10







List of co-cited articles
58 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry.
Ovidiu Chioncel, Alexandre Mebazaa, Veli-Pekka Harjola, Andrew J Coats, Massimo Francesco Piepoli, Maria G Crespo-Leiro, Cecile Laroche, Petar M Seferovic, Stefan D Anker, Roberto Ferrari,[...]. Eur J Heart Fail 2017
193
10

Multicentre analysis of hyperglycaemic hyperosmolar state and diabetic ketoacidosis in type 1 and type 2 diabetes.
S R Tittel, K M Sondern, M Weyer, T Poeplau, B M Sauer, M Schebek, K-H Ludwig, F Hammer, E Fröhlich-Reiterer, R W Holl. Acta Diabetol 2020
7
14

Design of a prospective patient-level pooled analysis of two parallel trials of empagliflozin in patients with established heart failure.
Milton Packer, Javed Butler, Gerasimos Filippatos, Faiez Zannad, Joao Pedro Ferreira, Cordula Zeller, Martina Brueckmann, Waheed Jamal, Stuart J Pocock, Stefan D Anker. Eur J Heart Fail 2020
10
10

Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors.
Rebecca J Vitale, Yannis K Valtis, Marie E McDonnell, Nadine E Palermo, Naomi D L Fisher. AACE Clin Case Rep 2021
20
10

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
10

Perioperative euglycemic diabetic ketoacidosis following use of SGLT-2 inhibitors after cardiac surgery.
João Paulo Jordão Pontes, Caroline Souto de Melo, Flávia Bittar Britto Arantes, Juan Thomaz Gabriel de Souza Ramos, Norma Sueli Pinheiro Módolo, Laís Helena Navarro E Lima. J Clin Anesth 2021
4
25

Drug-drug interaction software in clinical practice: a systematic review.
Tina Roblek, Tomaz Vaupotic, Ales Mrhar, Mitja Lainscak. Eur J Clin Pharmacol 2015
85
10


Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure.
Deepak L Bhatt, Michael Szarek, P Gabriel Steg, Christopher P Cannon, Lawrence A Leiter, Darren K McGuire, Julia B Lewis, Matthew C Riddle, Adriaan A Voors, Marco Metra,[...]. N Engl J Med 2021
517
10



Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial.
Stefan D Anker, Javed Butler, Gerasimos S Filippatos, Waheed Jamal, Afshin Salsali, Janet Schnee, Karen Kimura, Cordula Zeller, Jyothis George, Martina Brueckmann,[...]. Eur J Heart Fail 2019
148
10

Renal threshold for glucose reabsorption predicts diabetes improvement by sodium-glucose cotransporter 2 inhibitor therapy.
Aya Osaki, Shuichi Okada, Tsugumichi Saito, Eijiro Yamada, Kumeo Ono, Yawara Niijima, Hiroto Hoshi, Masanobu Yamada. J Diabetes Investig 2016
12
10

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
10

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
10

Comparative Pharmacokinetics and Pharmacodynamics of a Novel Sodium-Glucose Cotransporter 2 Inhibitor, DWP16001, with Dapagliflozin and Ipragliflozin.
Min-Koo Choi, So Jeong Nam, Hye-Young Ji, Mi Jie Park, Ji-Soo Choi, Im-Sook Song. Pharmaceutics 2020
9
11



Early benefits of empagliflozin in patients with or without heart failure: findings from EMPA-REG OUTCOME.
Pierpaolo Pellicori, Anne Pernille Ofstad, David Fitchett, Cordula Zeller, Christoph Wanner, Jyothis George, Bernard Zinman, Martina Brueckmann, JoAnn Lindenfeld. ESC Heart Fail 2020
10
10

Renal Handling of Ketones in Response to Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes.
Ele Ferrannini, Simona Baldi, Silvia Frascerra, Brenno Astiarraga, Elisabetta Barsotti, Aldo Clerico, Elza Muscelli. Diabetes Care 2017
94
10


Sodium-glucose cotransporter 2 inhibitor-induced euglycaemic diabetic ketoacidosis in heart failure with preserved ejection fraction.
Luka Cavka, Urska Bencak Ferko, Natasa Pitz, Zoranco Trpkovski, Mitja Lainscak. ESC Heart Fail 2021
3
33


Rare presentations of ketoacidosis: diabetic ketoalkalosis and ketoacidosis secondary to fasting and muscular dystrophy.
Mads Vandsted Svart, Thomas Schmidt Voss, Michael Bayat, Lene Ring Madsen, Lone Thing Andersen, Per Løgstrup Poulsen, Niels Møller. Clin Diabetes 2015
5
20


Empagliflozin-induced Diabetic Ketoacidosis Unmasking a Type 1 Diabetes Diagnosis.
Gretchen M Ray, Chelsea Rodriguez, Samantha M Schulman, Preeyaporn Sarangarm, Michelle Bardack, Matthew F Bouchonville. Clin Pract Cases Emerg Med 2019
3
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.